Dog Aging and Longevity Research

Canine aging research is generating insights into lifespan extension, age-related disease prevention, and quality of life preservation with direct welfare implications for companion dogs.

Key Facts

The Dog Aging Project is the largest longitudinal study of dog aging ever undertaken, enrolling over 35,000 dogs
Rapamycin, an mTOR inhibitor, showed 10% improved cardiac function in middle-aged dogs in early trials
Large breeds age faster than small breeds — Great Danes rarely exceed 8-10 years while Chihuahuas commonly reach 15-18 years
Caloric restriction extends lifespan and reduces age-related disease in dogs, paralleling findings in other species
Social factors including owner attachment security predict health outcomes in aging dogs beyond physical health metrics
Epigenetic age clocks for dogs allow biological age assessment independent of chronological age
Longitudinal behavioral and health monitoring enables detection of age-related decline before clinical disease appears

Welfare Considerations

Canine aging research is motivated not just by scientific curiosity but by the welfare imperative of reducing the suffering of age-related disease and extending the period of good quality life that dogs experience. The Dog Aging Project approaches dog health from a geroscience perspective — understanding aging itself as the primary risk factor for most late-life diseases and seeking interventions targeting aging biology rather than individual diseases. Welfare implications are profound: if rapamycin or other interventions can compress the period of age-related decline, dogs experience more years of healthy, high-quality life.

What You Can Do

Enroll your dog in the Dog Aging Project citizen science study
Implement moderate caloric restriction and maintain healthy body weight throughout your dog's life
Schedule annual geriatric wellness panels for dogs over age 7 to detect age-related changes early
Engage your veterinarian about emerging longevity interventions as evidence develops